Colorectal Cancer
Entity.
- Evidence
- 1,812 documents · 404 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 11 Mar 2026, last seen 18 Oct 2026
- Measured
- 6% of mentions say something specific about it; the rest only name it
- As of
- 19 Oct 2026
Where this comes from
- Medical Daily · 2026-10-18 · Total Ultraprocessed Food Intake Showed No Link to Colorectal Cancer in 461,682 Older Adults Followed Nearly 19 Years (opens the source in a new tab)
- Am J Case Rep · 2026-10-18 · An Integrated Approach to MSI-High Colorectal Cancer Therapy in a Young Patient: A Clinical Case. (opens the source in a new tab)
- Clin Transl Oncol · 2026-10-17 · Adjuvant treatment intensity in circulating tumour DNA-negative colorectal cancer: a systematic review and reconstructed individual patient data meta-analysis. (opens the source in a new tab)
- Oncotarget · 2026-10-16 · WIN-MTB-2024002 - WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer. (opens the source in a new tab)
- Medicine (Baltimore) · 2026-10-16 · Trends and projections of colorectal carcinoma mortality in U.S. adults, 1999-2050: A CDC WONDER-based ecological time-series analysis. (opens the source in a new tab)
- Mol Biol Rep · 2026-10-16 · Trans-vaccenic acid reduces HT-29 colorectal cancer cell viability and is associated with changes in apoptosis-, lipid metabolism-, and survival-related gene and candidate… (opens the source in a new tab)
- Endoscopy · 2026-10-16 · Serrated polyp detection rates beyond adenoma detection rate for postcolonoscopy colorectal cancer: findings from the SCREESCO trial. (opens the source in a new tab)
- Medicine (Baltimore) · 2026-10-16 · Research trends and hotspots in colorectal cancer screening: Bibliometric and visualization analysis (2015-2024). (opens the source in a new tab)
What is claimed about it
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- Verastem, Inc. (VSTM) Discusses New Clinical Data for VS-7375 KRAS G12D Inhibitor in Pancreatic, Lung, and Colorectal Cancers - Slideshow (NASDAQ:VSTM) 2026-10-14 - Seeking Alpha Could not check · first reported 14 Oct 2026
- ctDNA retesting to guide anti-EGFR therapy in later-line metastatic colorectal cancer Could not check · first reported 14 Oct 2026